Keywords
pyrazinamidase
drug resistance
culture quality
How to Cite
Abstract
The pyrazinamidase is a fast and easy to perform assay, recommended by the World Health Organization as an alternative technique to determine pyrazinamide resistant Mycobacterium tuberculosis strains. This study aimed to assess the reproducibility of negative results on pyrazinamidase assay using both primary cultures and respective subcultures, and to correlate them with original cultures quality, as well as their susceptibility profile to streptomycin (S), isoniazid (I), rifampin (R) and ethambutol (E). A total of 115 Mycobacterium tuberculosis cultures were analyzed, which the original growth produced negative results on pyrazinamidase assay, implying a resistance to pyrazinamide. The cultures quality was assessed and recorded; a second testing was performed using recent and abundant subcultures. Results from the first and the second tests demonstrated an agreement rate of 72.2%, and the cultures quality showed correlation with the results (p<0.001). Pyrazinamidase testing is useful when it is combined with other techniques for analyzing mycobacteria susceptibility to S, I, R, E since it is performed with high quality cultures which allow the use of abundant inocula.References
1. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Centro de Referência Professor Hélio Fraga. Manual de Bacteriologia da Tuberculose. 3ª ed. Edição comemorativa. Rio de Janeiro. 2005. 240p
2. OPAS-OMS. Manual de normas y procedimientos tecnicos para la bacteriologia de la tuberculosis. Parte III. Sensibilidad del Mycobacterium tuberculosis a las drogas. La identificación de micobactérias. Nota técnica 28. Buenos aires, Argentina: Centro Panamericano de Zoonosis, 1986.
3. Aono A, Hirano K, Hamasaki S, Abe C. Evaluationof BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosisto pyrazinamide (PZA): compared with the resultsof pyrazinamidase assay and Kyokuto PZA test. Diagn Microbiol Infect Dis 2002; 347-52.
4. Cheng SJ, Thibert L, Sanchez T, Heifets L, ZhangY. pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis: Spread of a Monoresistant Strain inQuebec, Canada. Antimicrob Agents Chemother2000; 44(3): 528-32.
5. Miyagi C, Yamane N, Yogesh B, Ano H, TakashimaT. Genetic and phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis complex isolates in Japan. Diagn Microbiol Infect Dis 2004; 48:111-6.
6. Rodrigues VFS, Telles MA, Ribeiro MO, CafrunePI, Rossetti MLS, Zaha A. Characterization of pnc AMutation in Pyrazinamide-Resistant Mycobacteriumtuberculosis in Brasil. Antimicrob Agents Chemother2005; 49(1): 444-6.
7. Scorpio A, Lindholm-Levy P, Heifets L, Gilman R,Siddiqi S, Cynamon M, Zhang Y. Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis. Antimicrob AgentsChemother 1997; 41(3): 540-3.
8. Zhang Y, Permar S, Sun Z. Conditions that may affectthe results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol2002; 51:42-9.
9. Shikama ML, Farrapo ACX, Nogueira CF, SilvaRFM, Sousa MS, Pini MIT, Amorim ABR, ErreraMC, Sato DN. Avaliação preliminar da suscetibilidade do Mycobacterium tuberculosis à pirazinamida pela detecção da pirazinamidase. BolInst Adolfo Lutz. 2002; 12(2): 11.
10. Martins MC, Ueki SYM, Giampaglia CMS, CredidioRA, Butuem IV, Ferrazoli L. Impacto da qualidade das culturas de micobactérias no resultado dos testes de identificação das espécies e de suscetibilidade às drogas. News Lab 2003; 58:70-8.
11. Collins CH, Grange JM, Yates MD. Tuberculosis Bacteriology: Organization and Practice, London: Butterworth Heinemann 2nd ed. 1997. 139p.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2007 Instituto Adolfo Lutz Journal